Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies

Journal of the American Medical Directors Association

Volumn 18, Issue 6, 2017, Pages 553.e1-553.e16

  Yoshimura, Yoshihiro ^a   Wakabayashi, Hidetaka ^b   Yamada, Minoru ^c   Kim, Hunkyung ^d   Harada, Atsushi ^e   Arai, Hidenori ^e  

^a Department of Neurology   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

drug; exercise; intervention; muscle mass; nutrition; Sarcopenia

Indexed keywords

AMINOTRANSFERASE; MK 0773; PLACEBO; PROTEIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; DATA BASE; DECISION MAKING; EXERCISE; HUMAN; META ANALYSIS; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SARCOPENIA; SIDE EFFECT; SYSTEMATIC REVIEW; WALKING SPEED; AGED; FEMALE; MALE; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SARCOPENIA;

EID: 85019935177     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2017.03.019     Document Type: Article

References (47)

1. 1 Rosenberg, I.H., Sarcopenia: Origins and clinical relevance. J Nutr 127 (1997), 990S–991S.
2. 2 Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
3. 3 Morley, J.E., Vellas, B., van Kan, G.A., et al. Frailty consensus: A call to action. J Am Med Dir Assoc 14 (2013), 392–397.
4. 4 Fried, L.P., Tangen, C.M., Walston, J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001), M146–M156.
5. 5 Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43 (2014), 748–759.
6. 6 Muscaritoli, M., Anker, S.D., Argilés, J., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29 (2010), 154–159.
7. 7 Fielding, R.A., Vellas, B., Evans, W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12 (2011), 249–256.
8. 8 Dam, T.T., Peters, K.W., Fragala, M., et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 69 (2014), 584–590.
9. 9 Morley, J.E., Abbatecola, A.M., Argiles, J.M., et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 12 (2011), 403–409.
10. 10 Studenski, S.A., Peters, K.W., Alley, D.E., et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69 (2014), 547–558.
11. 11 Cooper, C., Dere, W., Evans, W., et al. Frailty and sarcopenia: Definitions and outcome parameters. Osteoporos Int 23 (2012), 1839–1848.
12. 12 Chen, L.K., Liu, L.K., Woo, J., et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15 (2014), 95–101.
13. 13 Cao, L., Morley, J.E., Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc 17 (2016), 675–677.
14. 14 Malafarina, V., Uriz-Otano, F., Iniesta, R., Gil-Guerrero, L., Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: A systematic review. J Am Med Dir Assoc 14 (2013), 10–17.
15. 15 Moher, D., Liberati, A., Tetzlaff, J., et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, 2009, b2535.
16. 16 Japan Medical Abstracts Society. http://search.jamas.or.jp/ Accessed February 20, 2017.
17. 17 Higgins, J.P.T., Sally, G., Cochrane Handbook for Systematic Reviews of Interventions. 2011 Available at: www.cochrane-handbook.org.
18. 18 Guyatt, G.H., Oxman, A.D., Vist, G.E., et al., GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
19. 19 Kim, H.K., Suzuki, T., Saito, K., et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc 60 (2012), 16–23.
20. 20 Kim, H., Suzuki, T., Saito, K., et al. Effects of exercise and tea catechins on muscle mass, strength and walking ability in community-dwelling elderly Japanese sarcopenic women: A randomized controlled trial. Geriatr Gerontol Int 13 (2013), 458–465.
21. 21 Kim, H., Kim, M., Kojima, N., et al. Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity: A randomized controlled trial. J Am Med Dir Assoc 17 (2016), 1011–1019.
22. 22 Wei N, Pang MY, Ng SS, Ng GY. Optimal frequency/time combination of whole-body vibration training for improving muscle size and strength of people with age-related muscle loss (sarcopenia): A randomized controlled trial [published online August 31, 2016]. Geriatr Gerontol Int. http://dx.doi.org/10.1111/ggi.12878.
23. 23 Maltais, M.L., Ladouceur, J.P., Dionne, I.J., The effect of resistance training and different sources of postexercise protein supplementation on muscle mass and physical capacity in sarcopenic elderly men. J Strength Cond Res 30 (2016), 1680–1687.
24. 24 Papanicolaou, D.A., Ather, S.N., Zhu, H., et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging 17 (2013), 533–543.
25. 25 Zdzieblik, D., Oesser, S., Baumstark, M.W., et al. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: A randomised controlled trial. Br J Nutr 114 (2015), 1237–1245.
26. 26 Zanandrea, V., Giua, R., Costanzo, L., et al. Interventions against sarcopenia in older persons. Curr Pharm Des 20 (2014), 5983–6006.
27. 27 Wakabayashi, H., Sakuma, K., Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol 9 (2014), 171–180.
28. 28 Palop Montoro, M.V., Párraga Montilla, J.A., Lozano Aguilera, E., Arteaga Checa, M., Sarcopenia intervention with progressive resistance training and protein nutritional supplements. Nutr Hosp 31 (2015), 1481–1490.
29. 29 Morley, J.E., Frailty and sarcopenia: The new geriatric giants. Rev Invest Clin 68 (2016), 59–67.
30. 30 Chen, L.K., Lee, W.J., Peng, L.N., et al., Asian Working Group for Sarcopenia. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 17 (2016), 767.e1–767.e7.
31. 31 Kemmler, W., von Stengel, S., Alternative exercise technologies to fight against sarcopenia at old age: A series of studies and review. J Aging Res, 2012, 2012, 109013.
32. 32 Sitjà-Rabert, M., Martínez-Zapata, M.J., Fort Vanmeerhaeghe, A., et al. Effects of a whole body vibration (WBV) exercise intervention for institutionalized older people: a randomized, multicentre, parallel, clinical trial. J Am Med Dir Assoc 16 (2015), 125–131.
33. 33 Hickson, M., Nutritional interventions in sarcopenia: A critical review. Proc Nutr Soc 74 (2015), 378–386.
34. 34 Wu, H., Xia, Y., Jiang, J., et al. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr 61 (2015), 168–175.
35. 35 Deutz, N.E., Pereira, S.L., Hays, N.P., et al. Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin Nutr 32 (2013), 704–712.
36. 36 Martone, A.M., Lattanzio, F., Abbatecola, A.M., et al. Treating sarcopenia in older and oldest old. Curr Pharm Des 21 (2015), 1715–1722.
37. 37 Bauer, J.M., Verlaan, S., Bautmans, I., et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 16 (2015), 740–747.
38. 38 Komar, B., Schwingshackl, L., Hoffmann, G., Effects of leucine-rich protein supplements on anthropometric parameter and muscle strength in the elderly: A systematic review and meta-analysis. J Nutr Health Aging 19 (2015), 437–446.
39. 39 Bauer, J., Biolo, G., Cederholm, T., et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14 (2013), 542–559.
40. 40 Yoshimura, Y., Uchida, K., Jeong, S., Yamaga, M., Effects of nutritional supplements on muscle mass and activities of daily living in elderly rehabilitation patients with decreased muscle mass: A randomized controlled trial. J Nutr Health Aging 20 (2016), 185–191.
41. 41 Morley, J.E., Argiles, J.M., Evans, W.J., et al., Society for Sarcopenia, Cachexia, and Wasting Disease. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 11 (2010), 391–396.
42. 42 Onder, G., Della Vedova, C., Landi, F., Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 13 (2009), 746–756.
43. 43 Spira, D., Walston, J., Buchmann, N., et al. Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: Relation to muscle mass, strength and function: Data from the Berlin Aging Study-II (BASE-II). Drugs Aging 33 (2016), 829–837.
44. 44 Giovannini, S., Marzetti, E., Borst, S.E., Leeuwenburgh, C., Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev 129 (2008), 593–601.
45. 45 Morley, J.E., Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98 (2016), 319–333.
46. 46 White, T.A., LeBrasseur, N.K., Myostatin and sarcopenia: Opportunities and challenges—a mini-review. Gerontology 60 (2014), 289–293.
47. 47 Molfino, A., Amabile, M.I., Rossi Fanelli, F., Muscaritoli, M., Novel therapeutic options for cachexia and sarcopenia. Expert Opin Biol Ther 16 (2016), 1239–1244.